Effects of GW002, a novel recombinant human glucagon-like peptide-1 (GLP-1) analog fusion protein, on CHO recombinant cells and BKS-db mice.

Ji WW, Yu DA, Fan M, You M, Lu Y, Li EB, Xie N, Yan SS

Open source

DOI
10.1007/s00592-017-0992-z
Published
2017 Jul
Container
Acta diabetologica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00592-017-0992-z,
  title = {Effects of GW002, a novel recombinant human glucagon-like peptide-1 (GLP-1) analog fusion protein, on CHO recombinant cells and BKS-db mice.},
  author = {Ji WW and Yu DA and Fan M and You M and Lu Y and Li EB and Xie N and Yan SS},
  year = {2017},
  journal = {Acta diabetologica},
  doi = {10.1007/s00592-017-0992-z},
  url = {https://doi.org/10.1007/s00592-017-0992-z}
}

RIS

TY  - JOUR
TI  - Effects of GW002, a novel recombinant human glucagon-like peptide-1 (GLP-1) analog fusion protein, on CHO recombinant cells and BKS-db mice.
AU  - Ji WW
AU  - Yu DA
AU  - Fan M
AU  - You M
AU  - Lu Y
AU  - Li EB
AU  - Xie N
AU  - Yan SS
PY  - 2017
JO  - Acta diabetologica
DO  - 10.1007/s00592-017-0992-z
UR  - https://doi.org/10.1007/s00592-017-0992-z
ER  - 

APA

WW, J., DA, Y., M, F., M, Y., Y, L., EB, L., N, X., & SS, Y. (2017). Effects of GW002, a novel recombinant human glucagon-like peptide-1 (GLP-1) analog fusion protein, on CHO recombinant cells and BKS-db mice.. Acta diabetologica. https://doi.org/10.1007/s00592-017-0992-z

Source records